HEADER TRANSCRIPTION 10-DEC-01 1KKQ
TITLE CRYSTAL STRUCTURE OF THE HUMAN PPAR-ALPHA LIGAND-BINDING DOMAIN IN
TITLE 2 COMPLEX WITH AN ANTAGONIST GW6471 AND A SMRT COREPRESSOR MOTIF
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR;
COMPND 3 CHAIN: A, B, C, D;
COMPND 4 FRAGMENT: PPAR-ALPHA LBD;
COMPND 5 SYNONYM: PPAR-ALPHA LIGAND-BINDING DOMAIN;
COMPND 6 ENGINEERED: YES;
COMPND 7 MOL_ID: 2;
COMPND 8 MOLECULE: NUCLEAR RECEPTOR CO-REPRESSOR 2;
COMPND 9 CHAIN: E, F, G, H;
COMPND 10 FRAGMENT: SMRT RECEPTOR INTERACTING MOTIF;
COMPND 11 SYNONYM: NUCLEAR COREPRESSOR SMRT C-TERMINAL RECEPTOR INTERACTING
COMPND 12 MOTIF;
COMPND 13 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: HUMAN;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3);
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008;
SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 DE3;
SOURCE 9 EXPRESSION_SYSTEM_ORGAN: LIVER;
SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: T7 PROMOTER FROM PRSETA;
SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PRSETA;
SOURCE 12 MOL_ID: 2;
SOURCE 13 SYNTHETIC: YES;
SOURCE 14 OTHER_DETAILS: SMRT RECEPTOR INTERACTING MOTIF: THIS SEQUENCE OCCURS
SOURCE 15 NATURALLY IN HUMANS.
KEYWDS NUCLEAR COREPRESSOR NUCLEAR HORMONE RECEPTORS ANTAGONIST,
KEYWDS 2 TRANSCRIPTION
EXPDTA X-RAY DIFFRACTION
AUTHOR H.E.XU,T.B.STANLEY,V.G.MONTANA,M.H.LAMBERT,B.G.SHEARER,J.E.COBB,
AUTHOR 2 D.D.MCKEE,C.M.GALARDI,R.T.NOLTE,D.J.PARKS
REVDAT 7 16-AUG-23 1KKQ 1 REMARK
REVDAT 6 11-OCT-17 1KKQ 1 REMARK
REVDAT 5 01-FEB-17 1KKQ 1 AUTHOR
REVDAT 4 18-SEP-13 1KKQ 1 REMARK VERSN
REVDAT 3 24-FEB-09 1KKQ 1 VERSN
REVDAT 2 27-FEB-02 1KKQ 1 JRNL
REVDAT 1 20-FEB-02 1KKQ 0
JRNL AUTH H.E.XU,T.B.STANLEY,V.G.MONTANA,M.H.LAMBERT,B.G.SHEARER,
JRNL AUTH 2 J.E.COBB,D.D.MCKEE,C.M.GALARDI,K.D.PLUNKET,R.T.NOLTE,
JRNL AUTH 3 D.J.PARKS,J.T.MOORE,S.A.KLIEWER,T.M.WILLSON,J.B.STIMMEL
JRNL TITL STRUCTURAL BASIS FOR ANTAGONIST-MEDIATED RECRUITMENT OF
JRNL TITL 2 NUCLEAR CO-REPRESSORS BY PPARALPHA.
JRNL REF NATURE V. 415 813 2002
JRNL REFN ISSN 0028-0836
JRNL PMID 11845213
REMARK 1
REMARK 1 REFERENCE 1
REMARK 1 AUTH H.E.XU,M.H.LAMBERT,V.G.MONTANA,T.M.WILLSON
REMARK 1 TITL STRUCTURAL DETERMINANTS OF LIGAND BINDING SELECTIVITY
REMARK 1 TITL 2 BETWEEN THE PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS
REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 98 13919 2001
REMARK 1 REFN ISSN 0027-8424
REMARK 1 DOI 10.1073/PNAS.241410198
REMARK 2
REMARK 2 RESOLUTION. 3.00 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : CNX 2000
REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-
REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU,
REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS
REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA,
REMARK 3 : YIP,DZAKULA)
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.00
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.99
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 4983740.500
REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000
REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.8
REMARK 3 NUMBER OF REFLECTIONS : 29242
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.290
REMARK 3 R VALUE (WORKING SET) : 0.258
REMARK 3 FREE R VALUE : 0.290
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 8.000
REMARK 3 FREE R VALUE TEST SET COUNT : 2335
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006
REMARK 3
REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA.
REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL
REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL
REMARK 3 FREE R VALUE (NO CUTOFF) : NULL
REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL
REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL
REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL
REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 29737
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 6
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.00
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.19
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.60
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 4271
REMARK 3 BIN R VALUE (WORKING SET) : 0.3860
REMARK 3 BIN FREE R VALUE : 0.4210
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 7.90
REMARK 3 BIN FREE R VALUE TEST SET COUNT : 367
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.022
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 9096
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 180
REMARK 3 SOLVENT ATOMS : 330
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 50.00
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 50.10
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : 31.36000
REMARK 3 B22 (A**2) : -10.76000
REMARK 3 B33 (A**2) : -20.60000
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.45
REMARK 3 ESD FROM SIGMAA (A) : 0.55
REMARK 3 LOW RESOLUTION CUTOFF (A) : 50.0
REMARK 3
REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.53
REMARK 3 ESD FROM C-V SIGMAA (A) : 0.60
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.008
REMARK 3 BOND ANGLES (DEGREES) : 2.000
REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.50
REMARK 3 IMPROPER ANGLES (DEGREES) : 1.050
REMARK 3
REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA
REMARK 3 MAIN-CHAIN BOND (A**2) : 1.580 ; 1.500
REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.890 ; 2.000
REMARK 3 SIDE-CHAIN BOND (A**2) : 1.650 ; 2.000
REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.850 ; 2.500
REMARK 3
REMARK 3 BULK SOLVENT MODELING.
REMARK 3 METHOD USED : NULL
REMARK 3 KSOL : NULL
REMARK 3 BSOL : NULL
REMARK 3
REMARK 3 NCS MODEL : NULL
REMARK 3
REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT
REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL
REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL
REMARK 3
REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM
REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM
REMARK 3 PARAMETER FILE 3 : LOCALPARM.XPL
REMARK 3 PARAMETER FILE 4 : BSXPI3_BOND.XPL
REMARK 3 PARAMETER FILE 5 : NULL
REMARK 3 PARAMETER FILE 6 : NULL
REMARK 3 TOPOLOGY FILE 1 : INFILE_1
REMARK 3 TOPOLOGY FILE 2 : INFILE_2
REMARK 3 TOPOLOGY FILE 3 : INFILE_3
REMARK 3 TOPOLOGY FILE 4 : INFILE_4
REMARK 3 TOPOLOGY FILE 5 : INFILE_5
REMARK 3 TOPOLOGY FILE 6 : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 1KKQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 18-DEC-01.
REMARK 100 THE DEPOSITION ID IS D_1000015057.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 24-MAR-01
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 7.0
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : APS
REMARK 200 BEAMLINE : 17-ID
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.0
REMARK 200 MONOCHROMATOR : MONOCHROMATOR CRYSTAL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MAR
REMARK 200 DATA SCALING SOFTWARE : SCALEPACK
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29380
REMARK 200 RESOLUTION RANGE HIGH (A) : 3.000
REMARK 200 RESOLUTION RANGE LOW (A) : 20.990
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0
REMARK 200 DATA REDUNDANCY : 4.000
REMARK 200 R MERGE (I) : 0.02300
REMARK 200 R SYM (I) : 0.06600
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 23.3000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.00
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.11
REMARK 200 COMPLETENESS FOR SHELL (%) : 96.1
REMARK 200 DATA REDUNDANCY IN SHELL : 4.00
REMARK 200 R MERGE FOR SHELL (I) : 0.15800
REMARK 200 R SYM FOR SHELL (I) : 0.06200
REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.000
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: AMORE
REMARK 200 STARTING MODEL: 1K7L
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 55.49
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.76
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: PEG35K, PH 7.0, VAPOR DIFFUSION,
REMARK 280 HANGING DROP, TEMPERATURE 293K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X+1/2,-Y,Z+1/2
REMARK 290 3555 -X,Y+1/2,-Z+1/2
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 51.70450
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 61.97700
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 56.38650
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 61.97700
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 51.70450
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 56.38650
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1, 2, 3, 4
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 3390 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 14870 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -31.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, E
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 2
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 3360 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 15550 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -29.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, F
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 3
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 3120 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 15230 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -24.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, G
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 4
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 3280 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 15020 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -27.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: D, H
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470 M RES CSSEQI ATOMS
REMARK 470 THR A 200 OG1 CG2
REMARK 470 THR B 200 OG1 CG2
REMARK 470 THR C 200 OG1 CG2
REMARK 470 THR D 200 OG1 CG2
REMARK 470 ASN E 682 CG OD1 ND2
REMARK 470 LYS E 696 CG CD CE NZ
REMARK 470 GLN E 699 CG CD OE1 NE2
REMARK 470 ASN F 682 CG OD1 ND2
REMARK 470 GLN F 699 CG CD OE1 NE2
REMARK 470 ASN G 682 CG OD1 ND2
REMARK 470 LYS G 696 CG CD CE NZ
REMARK 470 GLN G 699 CG CD OE1 NE2
REMARK 470 ASN H 682 CG OD1 ND2
REMARK 470 LYS H 696 CG CD CE NZ
REMARK 470 GLN H 699 CG CD OE1 NE2
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT
REMARK 500
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE
REMARK 500 O ARG D 348 CG LYS D 349 1.74
REMARK 500 O GLY C 231 N ALA C 233 1.90
REMARK 500 O LEU G 685 CD1 ILE G 688 1.92
REMARK 500 O GLU B 451 OD1 ASP B 453 1.92
REMARK 500 O SER C 230 N LYS C 232 2.07
REMARK 500 O ASN A 219 NZ LYS A 224 2.10
REMARK 500 O LYS A 448 OG SER A 452 2.19
REMARK 500 O PHE D 343 OG SER D 346 2.19
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3
REMARK 500 GLU B 267 N - CA - C ANGL. DEV. = -19.8 DEGREES
REMARK 500 ASN C 236 N - CA - C ANGL. DEV. = -17.2 DEGREES
REMARK 500 LYS C 266 N - CA - C ANGL. DEV. = -17.4 DEGREES
REMARK 500 GLU C 451 N - CA - C ANGL. DEV. = -21.0 DEGREES
REMARK 500 LEU C 456 N - CA - C ANGL. DEV. = -16.7 DEGREES
REMARK 500 GLN C 461 N - CA - C ANGL. DEV. = -20.3 DEGREES
REMARK 500 ASN D 236 N - CA - C ANGL. DEV. = -19.3 DEGREES
REMARK 500 GLU D 462 N - CA - C ANGL. DEV. = 17.4 DEGREES
REMARK 500 GLY F 695 N - CA - C ANGL. DEV. = 19.0 DEGREES
REMARK 500 GLY G 695 N - CA - C ANGL. DEV. = 17.1 DEGREES
REMARK 500 LYS G 696 N - CA - C ANGL. DEV. = 16.8 DEGREES
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 ALA A 201 -58.78 -169.28
REMARK 500 ARG A 209 -19.25 -46.94
REMARK 500 LEU A 215 30.97 -75.66
REMARK 500 LYS A 216 -7.71 -154.32
REMARK 500 LEU A 229 -83.01 -55.87
REMARK 500 LYS A 232 -167.88 -162.01
REMARK 500 ALA A 233 54.73 72.77
REMARK 500 SER A 234 116.57 162.56
REMARK 500 ASN A 235 52.09 -113.56
REMARK 500 ASN A 236 74.23 -161.60
REMARK 500 PRO A 238 158.55 -45.26
REMARK 500 ALA A 250 -72.82 -37.77
REMARK 500 ALA A 256 25.51 34.41
REMARK 500 VAL A 259 30.98 -144.36
REMARK 500 ALA A 260 -37.15 -165.37
REMARK 500 GLN A 264 11.21 -147.53
REMARK 500 ASN A 265 14.71 -169.71
REMARK 500 GLU A 267 139.36 -39.04
REMARK 500 CYS A 276 -17.11 -39.60
REMARK 500 CYS A 278 21.68 -75.81
REMARK 500 VAL A 281 -34.17 -147.85
REMARK 500 PRO A 295 124.56 -33.80
REMARK 500 LEU A 300 132.32 -22.77
REMARK 500 LYS A 327 -4.90 -54.96
REMARK 500 SER A 346 -18.49 178.10
REMARK 500 CYS A 352 -9.21 -44.16
REMARK 500 VAL A 394 11.05 -59.50
REMARK 500 SER A 414 32.58 -99.49
REMARK 500 ASN A 415 -32.36 -139.29
REMARK 500 PRO A 417 -0.84 -58.55
REMARK 500 ASP A 419 60.01 -115.41
REMARK 500 GLN A 442 -70.07 -65.04
REMARK 500 SER A 452 40.80 30.99
REMARK 500 ALA A 454 79.22 -108.61
REMARK 500 ALA A 455 -166.00 -110.48
REMARK 500 PRO A 458 45.67 -79.93
REMARK 500 GLU A 462 -16.34 -170.85
REMARK 500 ILE A 463 -33.22 -136.31
REMARK 500 ARG A 465 -93.80 -70.14
REMARK 500 ASP A 466 79.35 -57.29
REMARK 500 MET A 467 -36.03 -157.82
REMARK 500 LEU B 229 -74.23 -65.34
REMARK 500 LYS B 232 65.70 19.36
REMARK 500 ALA B 233 53.99 -102.86
REMARK 500 SER B 234 133.66 166.27
REMARK 500 ASN B 236 67.22 72.96
REMARK 500 MET B 244 -14.74 -45.66
REMARK 500 ALA B 250 -86.53 -60.19
REMARK 500 ALA B 260 51.02 -177.77
REMARK 500 ASN B 261 -67.12 -122.35
REMARK 500
REMARK 500 THIS ENTRY HAS 162 RAMACHANDRAN OUTLIERS.
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY
REMARK 500
REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY
REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER
REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME;
REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 500 I=INSERTION CODE).
REMARK 500
REMARK 500 M RES CSSEQI ANGLE
REMARK 500 LYS D 349 -10.92
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 471 A 775
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 471 B 776
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 471 C 777
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC4
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 471 D 778
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 1K7L RELATED DB: PDB
REMARK 900 THE 2.5 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE HUMAN
REMARK 900 PPARALPHA LIGAND BINDING DOMAIN BOUND WITH GW409544 AND A CO-
REMARK 900 ACTIVATOR PEPTIDE
REMARK 900 RELATED ID: 1K74 RELATED DB: PDB
REMARK 900 THE 2.3 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE HETERODIMER OF
REMARK 900 THE HUMAN PPARGAMMA AND RXRALPHA LIGAND BINDING DOMAINS
REMARK 900 RESPECTIVELY BOUND WITH GW409544 AND 9-CIS RETINOIC ACID AND CO-
REMARK 900 ACTIVATOR PEPTIDES
DBREF 1KKQ A 200 468 UNP Q07869 PPAR_HUMAN 200 468
DBREF 1KKQ B 200 468 UNP Q07869 PPAR_HUMAN 200 468
DBREF 1KKQ C 200 468 UNP Q07869 PPAR_HUMAN 200 468
DBREF 1KKQ D 200 468 UNP Q07869 PPAR_HUMAN 200 468
DBREF 1KKQ E 682 700 UNP Q9Y618 NCOR2_HUMAN 2339 2357
DBREF 1KKQ G 682 700 UNP Q9Y618 NCOR2_HUMAN 2339 2357
DBREF 1KKQ H 682 700 UNP Q9Y618 NCOR2_HUMAN 2339 2357
DBREF 1KKQ F 682 700 UNP Q9Y618 NCOR2_HUMAN 2339 2357
SEQRES 1 A 269 THR ALA ASP LEU LYS SER LEU ALA LYS ARG ILE TYR GLU
SEQRES 2 A 269 ALA TYR LEU LYS ASN PHE ASN MET ASN LYS VAL LYS ALA
SEQRES 3 A 269 ARG VAL ILE LEU SER GLY LYS ALA SER ASN ASN PRO PRO
SEQRES 4 A 269 PHE VAL ILE HIS ASP MET GLU THR LEU CYS MET ALA GLU
SEQRES 5 A 269 LYS THR LEU VAL ALA LYS LEU VAL ALA ASN GLY ILE GLN
SEQRES 6 A 269 ASN LYS GLU ALA GLU VAL ARG ILE PHE HIS CYS CYS GLN
SEQRES 7 A 269 CYS THR SER VAL GLU THR VAL THR GLU LEU THR GLU PHE
SEQRES 8 A 269 ALA LYS ALA ILE PRO GLY PHE ALA ASN LEU ASP LEU ASN
SEQRES 9 A 269 ASP GLN VAL THR LEU LEU LYS TYR GLY VAL TYR GLU ALA
SEQRES 10 A 269 ILE PHE ALA MET LEU SER SER VAL MET ASN LYS ASP GLY
SEQRES 11 A 269 MET LEU VAL ALA TYR GLY ASN GLY PHE ILE THR ARG GLU
SEQRES 12 A 269 PHE LEU LYS SER LEU ARG LYS PRO PHE CYS ASP ILE MET
SEQRES 13 A 269 GLU PRO LYS PHE ASP PHE ALA MET LYS PHE ASN ALA LEU
SEQRES 14 A 269 GLU LEU ASP ASP SER ASP ILE SER LEU PHE VAL ALA ALA
SEQRES 15 A 269 ILE ILE CYS CYS GLY ASP ARG PRO GLY LEU LEU ASN VAL
SEQRES 16 A 269 GLY HIS ILE GLU LYS MET GLN GLU GLY ILE VAL HIS VAL
SEQRES 17 A 269 LEU ARG LEU HIS LEU GLN SER ASN HIS PRO ASP ASP ILE
SEQRES 18 A 269 PHE LEU PHE PRO LYS LEU LEU GLN LYS MET ALA ASP LEU
SEQRES 19 A 269 ARG GLN LEU VAL THR GLU HIS ALA GLN LEU VAL GLN ILE
SEQRES 20 A 269 ILE LYS LYS THR GLU SER ASP ALA ALA LEU HIS PRO LEU
SEQRES 21 A 269 LEU GLN GLU ILE TYR ARG ASP MET TYR
SEQRES 1 B 269 THR ALA ASP LEU LYS SER LEU ALA LYS ARG ILE TYR GLU
SEQRES 2 B 269 ALA TYR LEU LYS ASN PHE ASN MET ASN LYS VAL LYS ALA
SEQRES 3 B 269 ARG VAL ILE LEU SER GLY LYS ALA SER ASN ASN PRO PRO
SEQRES 4 B 269 PHE VAL ILE HIS ASP MET GLU THR LEU CYS MET ALA GLU
SEQRES 5 B 269 LYS THR LEU VAL ALA LYS LEU VAL ALA ASN GLY ILE GLN
SEQRES 6 B 269 ASN LYS GLU ALA GLU VAL ARG ILE PHE HIS CYS CYS GLN
SEQRES 7 B 269 CYS THR SER VAL GLU THR VAL THR GLU LEU THR GLU PHE
SEQRES 8 B 269 ALA LYS ALA ILE PRO GLY PHE ALA ASN LEU ASP LEU ASN
SEQRES 9 B 269 ASP GLN VAL THR LEU LEU LYS TYR GLY VAL TYR GLU ALA
SEQRES 10 B 269 ILE PHE ALA MET LEU SER SER VAL MET ASN LYS ASP GLY
SEQRES 11 B 269 MET LEU VAL ALA TYR GLY ASN GLY PHE ILE THR ARG GLU
SEQRES 12 B 269 PHE LEU LYS SER LEU ARG LYS PRO PHE CYS ASP ILE MET
SEQRES 13 B 269 GLU PRO LYS PHE ASP PHE ALA MET LYS PHE ASN ALA LEU
SEQRES 14 B 269 GLU LEU ASP ASP SER ASP ILE SER LEU PHE VAL ALA ALA
SEQRES 15 B 269 ILE ILE CYS CYS GLY ASP ARG PRO GLY LEU LEU ASN VAL
SEQRES 16 B 269 GLY HIS ILE GLU LYS MET GLN GLU GLY ILE VAL HIS VAL
SEQRES 17 B 269 LEU ARG LEU HIS LEU GLN SER ASN HIS PRO ASP ASP ILE
SEQRES 18 B 269 PHE LEU PHE PRO LYS LEU LEU GLN LYS MET ALA ASP LEU
SEQRES 19 B 269 ARG GLN LEU VAL THR GLU HIS ALA GLN LEU VAL GLN ILE
SEQRES 20 B 269 ILE LYS LYS THR GLU SER ASP ALA ALA LEU HIS PRO LEU
SEQRES 21 B 269 LEU GLN GLU ILE TYR ARG ASP MET TYR
SEQRES 1 C 269 THR ALA ASP LEU LYS SER LEU ALA LYS ARG ILE TYR GLU
SEQRES 2 C 269 ALA TYR LEU LYS ASN PHE ASN MET ASN LYS VAL LYS ALA
SEQRES 3 C 269 ARG VAL ILE LEU SER GLY LYS ALA SER ASN ASN PRO PRO
SEQRES 4 C 269 PHE VAL ILE HIS ASP MET GLU THR LEU CYS MET ALA GLU
SEQRES 5 C 269 LYS THR LEU VAL ALA LYS LEU VAL ALA ASN GLY ILE GLN
SEQRES 6 C 269 ASN LYS GLU ALA GLU VAL ARG ILE PHE HIS CYS CYS GLN
SEQRES 7 C 269 CYS THR SER VAL GLU THR VAL THR GLU LEU THR GLU PHE
SEQRES 8 C 269 ALA LYS ALA ILE PRO GLY PHE ALA ASN LEU ASP LEU ASN
SEQRES 9 C 269 ASP GLN VAL THR LEU LEU LYS TYR GLY VAL TYR GLU ALA
SEQRES 10 C 269 ILE PHE ALA MET LEU SER SER VAL MET ASN LYS ASP GLY
SEQRES 11 C 269 MET LEU VAL ALA TYR GLY ASN GLY PHE ILE THR ARG GLU
SEQRES 12 C 269 PHE LEU LYS SER LEU ARG LYS PRO PHE CYS ASP ILE MET
SEQRES 13 C 269 GLU PRO LYS PHE ASP PHE ALA MET LYS PHE ASN ALA LEU
SEQRES 14 C 269 GLU LEU ASP ASP SER ASP ILE SER LEU PHE VAL ALA ALA
SEQRES 15 C 269 ILE ILE CYS CYS GLY ASP ARG PRO GLY LEU LEU ASN VAL
SEQRES 16 C 269 GLY HIS ILE GLU LYS MET GLN GLU GLY ILE VAL HIS VAL
SEQRES 17 C 269 LEU ARG LEU HIS LEU GLN SER ASN HIS PRO ASP ASP ILE
SEQRES 18 C 269 PHE LEU PHE PRO LYS LEU LEU GLN LYS MET ALA ASP LEU
SEQRES 19 C 269 ARG GLN LEU VAL THR GLU HIS ALA GLN LEU VAL GLN ILE
SEQRES 20 C 269 ILE LYS LYS THR GLU SER ASP ALA ALA LEU HIS PRO LEU
SEQRES 21 C 269 LEU GLN GLU ILE TYR ARG ASP MET TYR
SEQRES 1 D 269 THR ALA ASP LEU LYS SER LEU ALA LYS ARG ILE TYR GLU
SEQRES 2 D 269 ALA TYR LEU LYS ASN PHE ASN MET ASN LYS VAL LYS ALA
SEQRES 3 D 269 ARG VAL ILE LEU SER GLY LYS ALA SER ASN ASN PRO PRO
SEQRES 4 D 269 PHE VAL ILE HIS ASP MET GLU THR LEU CYS MET ALA GLU
SEQRES 5 D 269 LYS THR LEU VAL ALA LYS LEU VAL ALA ASN GLY ILE GLN
SEQRES 6 D 269 ASN LYS GLU ALA GLU VAL ARG ILE PHE HIS CYS CYS GLN
SEQRES 7 D 269 CYS THR SER VAL GLU THR VAL THR GLU LEU THR GLU PHE
SEQRES 8 D 269 ALA LYS ALA ILE PRO GLY PHE ALA ASN LEU ASP LEU ASN
SEQRES 9 D 269 ASP GLN VAL THR LEU LEU LYS TYR GLY VAL TYR GLU ALA
SEQRES 10 D 269 ILE PHE ALA MET LEU SER SER VAL MET ASN LYS ASP GLY
SEQRES 11 D 269 MET LEU VAL ALA TYR GLY ASN GLY PHE ILE THR ARG GLU
SEQRES 12 D 269 PHE LEU LYS SER LEU ARG LYS PRO PHE CYS ASP ILE MET
SEQRES 13 D 269 GLU PRO LYS PHE ASP PHE ALA MET LYS PHE ASN ALA LEU
SEQRES 14 D 269 GLU LEU ASP ASP SER ASP ILE SER LEU PHE VAL ALA ALA
SEQRES 15 D 269 ILE ILE CYS CYS GLY ASP ARG PRO GLY LEU LEU ASN VAL
SEQRES 16 D 269 GLY HIS ILE GLU LYS MET GLN GLU GLY ILE VAL HIS VAL
SEQRES 17 D 269 LEU ARG LEU HIS LEU GLN SER ASN HIS PRO ASP ASP ILE
SEQRES 18 D 269 PHE LEU PHE PRO LYS LEU LEU GLN LYS MET ALA ASP LEU
SEQRES 19 D 269 ARG GLN LEU VAL THR GLU HIS ALA GLN LEU VAL GLN ILE
SEQRES 20 D 269 ILE LYS LYS THR GLU SER ASP ALA ALA LEU HIS PRO LEU
SEQRES 21 D 269 LEU GLN GLU ILE TYR ARG ASP MET TYR
SEQRES 1 E 19 ASN MET GLY LEU GLU ALA ILE ILE ARG LYS ALA LEU MET
SEQRES 2 E 19 GLY LYS TYR ASP GLN TRP
SEQRES 1 F 19 ASN MET GLY LEU GLU ALA ILE ILE ARG LYS ALA LEU MET
SEQRES 2 F 19 GLY LYS TYR ASP GLN TRP
SEQRES 1 G 19 ASN MET GLY LEU GLU ALA ILE ILE ARG LYS ALA LEU MET
SEQRES 2 G 19 GLY LYS TYR ASP GLN TRP
SEQRES 1 H 19 ASN MET GLY LEU GLU ALA ILE ILE ARG LYS ALA LEU MET
SEQRES 2 H 19 GLY LYS TYR ASP GLN TRP
HET 471 A 775 45
HET 471 B 776 45
HET 471 C 777 45
HET 471 D 778 45
HETNAM 471 N-((2S)-2-({(1Z)-1-METHYL-3-OXO-3-[4-(TRIFLUOROMETHYL)
HETNAM 2 471 PHENYL]PROP-1-ENYL}AMINO)-3-{4-[2-(5-METHYL-2-PHENYL-
HETNAM 3 471 1,3-OXAZOL-4-YL)ETHOXY]PHENYL}PROPYL)PROPANAMIDE
FORMUL 9 471 4(C35 H36 F3 N3 O4)
FORMUL 13 HOH *330(H2 O)
HELIX 1 1 LYS A 204 LEU A 215 1 12
HELIX 2 2 ASN A 221 SER A 230 1 10
HELIX 3 3 ASP A 243 VAL A 255 1 13
HELIX 4 4 ARG A 271 CYS A 276 1 6
HELIX 5 5 VAL A 281 LYS A 292 1 12
HELIX 6 6 ASP A 301 TYR A 311 1 11
HELIX 7 7 GLY A 312 SER A 322 1 11
HELIX 8 8 ALA A 333 GLY A 335 5 3
HELIX 9 9 ARG A 341 LYS A 345 1 5
HELIX 10 10 PRO A 350 ASP A 353 5 4
HELIX 11 11 ILE A 354 ASN A 366 1 13
HELIX 12 12 ASP A 371 CYS A 384 1 14
HELIX 13 13 GLY A 395 LEU A 412 1 18
HELIX 14 14 PHE A 421 LEU A 433 1 13
HELIX 15 15 LEU A 433 GLN A 445 1 13
HELIX 16 16 SER B 205 PHE B 218 1 14
HELIX 17 17 ASN B 221 SER B 230 1 10
HELIX 18 18 THR B 246 VAL B 255 1 10
HELIX 19 19 ALA B 268 CYS B 275 1 8
HELIX 20 20 SER B 280 LYS B 292 1 13
HELIX 21 21 ASP B 301 SER B 322 1 22
HELIX 22 22 ARG B 341 LYS B 345 1 5
HELIX 23 23 MET B 355 ASN B 366 1 12
HELIX 24 24 ALA B 367 GLU B 369 5 3
HELIX 25 25 ASP B 371 CYS B 384 1 14
HELIX 26 26 ASN B 393 HIS B 416 1 24
HELIX 27 27 PHE B 421 ILE B 446 1 26
HELIX 28 28 LYS C 204 ALA C 213 1 10
HELIX 29 29 ALA C 213 PHE C 218 1 6
HELIX 30 30 ASN C 221 SER C 230 1 10
HELIX 31 31 ASP C 243 VAL C 255 1 13
HELIX 32 32 GLU C 267 ILE C 272 1 6
HELIX 33 33 GLU C 282 ILE C 294 1 13
HELIX 34 34 ASP C 301 GLY C 312 1 12
HELIX 35 35 TYR C 314 LEU C 321 1 8
HELIX 36 36 SER C 322 MET C 325 5 4
HELIX 37 37 ALA C 333 GLY C 335 5 3
HELIX 38 38 ARG C 341 SER C 346 1 6
HELIX 39 39 PRO C 350 ILE C 354 5 5
HELIX 40 40 MET C 355 ASN C 366 1 12
HELIX 41 41 ALA C 367 GLU C 369 5 3
HELIX 42 42 ASP C 371 CYS C 384 1 14
HELIX 43 43 GLY C 395 HIS C 416 1 22
HELIX 44 44 LEU C 422 GLN C 442 1 21
HELIX 45 45 LEU D 203 PHE D 218 1 16
HELIX 46 46 ASN D 221 LEU D 229 1 9
HELIX 47 47 ASP D 243 THR D 253 1 11
HELIX 48 48 LYS D 257 GLY D 262 1 6
HELIX 49 49 HIS D 274 ILE D 294 1 21
HELIX 50 50 GLY D 296 LEU D 300 5 5
HELIX 51 51 ASP D 301 SER D 322 1 22
HELIX 52 52 ALA D 333 GLY D 335 5 3
HELIX 53 53 ARG D 341 LYS D 345 1 5
HELIX 54 54 PHE D 351 ASN D 366 1 16
HELIX 55 55 ALA D 367 GLU D 369 5 3
HELIX 56 56 ASP D 371 ILE D 382 1 12
HELIX 57 57 GLY D 395 GLN D 413 1 19
HELIX 58 58 PHE D 421 GLN D 445 1 25
HELIX 59 59 LEU E 685 ALA E 692 1 8
HELIX 60 60 LEU F 685 LEU F 693 1 9
HELIX 61 61 LEU G 685 LYS G 691 1 7
HELIX 62 62 LEU H 685 LYS H 691 1 7
SHEET 1 A 3 PHE A 239 ILE A 241 0
SHEET 2 A 3 GLY A 337 THR A 340 1 O PHE A 338 N PHE A 239
SHEET 3 A 3 GLY A 329 VAL A 332 -1 N VAL A 332 O GLY A 337
SHEET 1 B 4 PHE B 239 ILE B 241 0
SHEET 2 B 4 GLY B 337 THR B 340 1 O THR B 340 N ILE B 241
SHEET 3 B 4 GLY B 329 VAL B 332 -1 N VAL B 332 O GLY B 337
SHEET 4 B 4 MET B 325 ASN B 326 -1 N ASN B 326 O GLY B 329
SHEET 1 C 3 PHE C 239 ILE C 241 0
SHEET 2 C 3 GLY C 337 THR C 340 1 O PHE C 338 N PHE C 239
SHEET 3 C 3 GLY C 329 VAL C 332 -1 N VAL C 332 O GLY C 337
SHEET 1 D 4 PHE D 239 ILE D 241 0
SHEET 2 D 4 GLY D 337 THR D 340 1 O PHE D 338 N ILE D 241
SHEET 3 D 4 GLY D 329 VAL D 332 -1 N MET D 330 O ILE D 339
SHEET 4 D 4 MET D 325 ASN D 326 -1 N ASN D 326 O GLY D 329
CISPEP 1 LYS A 349 PRO A 350 0 0.05
CISPEP 2 LYS B 349 PRO B 350 0 0.38
CISPEP 3 LYS C 349 PRO C 350 0 -0.34
CISPEP 4 LYS D 349 PRO D 350 0 0.28
SITE 1 AC1 15 LEU A 254 GLU A 269 ILE A 272 PHE A 273
SITE 2 AC1 15 CYS A 275 CYS A 276 SER A 280 TYR A 314
SITE 3 AC1 15 VAL A 332 PHE A 351 ILE A 354 HIS A 440
SITE 4 AC1 15 VAL A 444 LEU A 456 HOH A 798
SITE 1 AC2 14 LEU B 254 ILE B 272 CYS B 276 THR B 279
SITE 2 AC2 14 SER B 280 TYR B 314 MET B 330 VAL B 332
SITE 3 AC2 14 LEU B 344 PHE B 351 ILE B 354 MET B 355
SITE 4 AC2 14 HIS B 440 HOH B 794
SITE 1 AC3 15 ILE C 241 ILE C 272 PHE C 273 CYS C 275
SITE 2 AC3 15 CYS C 276 GLN C 277 THR C 279 SER C 280
SITE 3 AC3 15 TYR C 314 MET C 330 VAL C 332 PHE C 351
SITE 4 AC3 15 ILE C 354 HIS C 440 HOH C 816
SITE 1 AC4 13 LEU D 254 GLU D 269 ILE D 272 PHE D 273
SITE 2 AC4 13 CYS D 276 GLN D 277 SER D 280 TYR D 314
SITE 3 AC4 13 MET D 330 VAL D 332 LEU D 344 PHE D 351
SITE 4 AC4 13 HOH D 779
CRYST1 103.409 112.773 123.954 90.00 90.00 90.00 P 21 21 21 16
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.009670 0.000000 0.000000 0.00000
SCALE2 0.000000 0.008867 0.000000 0.00000
SCALE3 0.000000 0.000000 0.008068 0.00000